Synthesis, characterization and antitumor activity study of some cyclometalated organoplatinum(II) complexes containing aromatic N-donor ligands

[1]  J. Ruiz,et al.  Synthesis and antiproliferative activity of a C,N-cycloplatinated(II) complex with a potentially intercalative anthraquinone pendant. , 2011, Inorganic chemistry.

[2]  M. Schürmann,et al.  On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum. , 2009, Dalton transactions.

[3]  E. Szłyk,et al.  1H, 13C, 15N and 195Pt NMR studies of Au(III) and Pt(II) chloride organometallics with 2‐phenylpyridine , 2009, Magnetic resonance in chemistry : MRC.

[4]  Á. Montaña,et al.  The rational design of anticancer platinum complexes: the importance of the structure-activity relationship. , 2009, Current medicinal chemistry.

[5]  Lei Liu,et al.  Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes. , 2009, European journal of medicinal chemistry.

[6]  P. Sadler,et al.  Photoactive trans ammine/amine diazido platinum(IV) complexes , 2009 .

[7]  T. Hambley,et al.  Enantioselectivity and stereoselectivity in the reactions of the enantiomers of the platinum complex [PtCl2(ahaz)] (ahaz=3(R)- or 3(S)-aminohexahydroazepine) with DNA. , 2009, Journal of inorganic biochemistry.

[8]  D. Gibson,et al.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts , 2009, JBIC Journal of Biological Inorganic Chemistry.

[9]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[10]  A. Crispini,et al.  Efficient, Ultrafast, Microwave‐Assisted Syntheses of Cycloplatinated Complexes , 2007 .

[11]  G. Clarkson,et al.  Cyclometallated platinum(II) complexes: oxidation to, and C-H activation by, platinum(IV). , 2007, Dalton transactions.

[12]  M. Crespo,et al.  A comparative study of the structures and reactivity of cyclometallated platinum compounds of N-benzylidenebenzylamines and cycloplatination of a primary amine. , 2007, Dalton transactions.

[13]  S. W. Thomas,et al.  Dark-field oxidative addition-based chemosensing: new bis-cyclometalated PtII complexes and phosphorescent detection of cyanogen halides. , 2006, Journal of the American Chemical Society.

[14]  F. Avilés,et al.  Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds. , 2006, Inorganic chemistry.

[15]  F. Avilés,et al.  New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA. , 2005, Inorganic chemistry.

[16]  G. Deacon,et al.  In vitro and in vivo studies of neutral cyclometallated complexes against murine leukæmias , 2005 .

[17]  G. Deacon,et al.  Effect of charge and surface area on the cytotoxicity of cationic metallointercalation reagents , 2005 .

[18]  Elena Monti,et al.  Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach. , 2005, Journal of medicinal chemistry.

[19]  J. Collins,et al.  Multi-nuclear platinum complexes as anti-cancer drugs , 2003 .

[20]  Sergey Lamansky,et al.  Synthesis and characterization of phosphorescent cyclometalated platinum complexes. , 2001, Inorganic chemistry.

[21]  T. Okada,et al.  Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance. , 2001, Journal of medicinal chemistry.

[22]  T. Okada,et al.  Platinum (II) complex with cyclometalating 2-phenylpyridine ligand showing high cytotoxicity against cisplatin-resistant cell. , 2001, Journal of inorganic biochemistry.

[23]  Ji-cheng Shi,et al.  Chiral Phosphine Ligands Derived from Sugars. 16. Design and Synthesis of Platinum Anticancer Compounds with Carbohydrate Ligand , 1999 .

[24]  G. Jaouen.  Bioorganometallics: Biomolecules, Labeling, Medicine , 1994 .

[25]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.